Cargando…
The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m(6)A RNA methylation reading protein Ythdf2
Pathological cardiac hypertrophy is a key contributor in heart failure (HF). Long non-coding RNAs (lncRNAs) and N(6)-methyladenosine (m(6)A) modification play a vital role in cardiac hypertrophy respectively. Nevertheless, the interaction between lncRNA and m(6)A methylase in cardiac hypertrophy is...
Autores principales: | Yang, Yiqing, Mbikyo, Muisha B., Zhang, Junzhe, Zhang, Yuan, Zhang, Naijin, Li, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983679/ https://www.ncbi.nlm.nih.gov/pubmed/35383152 http://dx.doi.org/10.1038/s41420-022-00977-8 |
Ejemplares similares
-
Research Progress on N(6)-adenosylate Methylation RNA Modification in Heart Failure Remodeling
por: Yang, Yiqing, et al.
Publicado: (2023) -
Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021) -
lncRNA MIAT promotes cell invasion and migration in esophageal cancer
por: Zhang, Weiguo, et al.
Publicado: (2020) -
LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019) -
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Todoerti, Katia, et al.
Publicado: (2021)